ARVINAS, INC. Shares Issued, Value, Share-based Payment Arrangement, before Forfeiture
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- ARVINAS, INC. shares issued, value, share-based payment arrangement, before forfeiture for the quarter ending 2026-06-30 was $500.00K, a 0.00% change year-over-year.
- ARVINAS, INC. shares issued, value, share-based payment arrangement, before forfeiture for the quarter ending 2025-06-30 was $500.00K.
- ARVINAS, INC. shares issued, value, share-based payment arrangement, before forfeiture for the quarter ending 2018-12-31 was $5.44M, a 6523.84% increase year-over-year.
- ARVINAS, INC. shares issued, value, share-based payment arrangement, before forfeiture for the quarter ending 2018-09-30 was $5.06M.
- ARVINAS, INC. shares issued, value, share-based payment arrangement, before forfeiture for fiscal 2018 was $11.63M, a 4646.13% increase from fiscal 2017.
- ARVINAS, INC. shares issued, value, share-based payment arrangement, before forfeiture for fiscal 2017 was $245.05K.
| Period end | Shares Issued, Value, Share-based Payment Arrangement, before Forfeiture 3 month | Shares Issued, Value, Share-based Payment Arrangement, before Forfeiture 12 month |
|---|---|---|
| 2026-06-30 | $500.00K 10-Q · filed 2026-08-04 | |
| 2025-06-30 | $500.00K 10-Q · filed 2026-08-04 | |
| 2018-12-31 | $5.44M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | $11.63M 10-K · filed 2021-03-01 |
| 2018-09-30 | $5.06M 10-Q · filed 2019-11-04 | $6.27M derived: sum of 4 quarters · filed 2019-11-04 |
| 2018-06-30 | $979.87K 10-Q · filed 2019-08-05 | |
| 2018-03-31 | $146.73K 10-Q · filed 2019-05-09 | |
| 2017-12-31 | $82.15K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-26 | $245.05K 10-K · filed 2019-03-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PUMA BIOTECHNOLOGY, INC. (PBYI) | United States | $0.507B | 15.53 |
| Evolus, Inc. (EOLS) | United States | $0.519B | -13.32 |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | United States | $0.499B | -10.81 |
| CRESCENT BIOPHARMA, INC. (CBIO) | United States | $0.529B | -5.20 |
| Ovid Therapeutics Inc. (OVID) | United States | $0.487B | -14.41 |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B | |
| ASSEMBLY BIOSCIENCES, INC. (ASMB) | United States | $0.481B | -13,053.96 |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 |